# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-002537
Filing Date
2023-04-25
Accepted
2023-04-25 17:14:19
Documents
7
Period of Report
2023-05-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | f6k_042523.htm | 6-K | 11876
2 | EXHIBIT 99.1 | exh_991.htm | EX-99.1 | 569302
3 | EXHIBIT 99.2 | exh_992.htm | EX-99.2 | 1007
4 | GRAPHIC | logo.jpg | GRAPHIC | 14828
5 | GRAPHIC | perf.jpg | GRAPHIC | 34861
6 | GRAPHIC | proxy_1.jpg | GRAPHIC | 282720
7 | GRAPHIC | proxy_2.jpg | GRAPHIC | 395231
| Complete submission text file | 0001171843-23-002537.txt |  | 1584746

Mailing Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5
Business Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5 647-476-1350
Profound Medical Corp. (Filer) CIK: 0001628808 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39032 | Film No.: 23845823
SIC: 3841 Surgical & Medical Instruments & Apparatus